Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$160.42 - $256.21 $337,844 - $539,578
-2,106 Reduced 51.92%
1,950 $365,000
Q2 2022

Aug 11, 2022

BUY
$140.68 - $188.02 $243,376 - $325,274
1,730 Added 74.38%
4,056 $659,000
Q1 2022

May 12, 2022

SELL
$161.19 - $257.96 $345,430 - $552,808
-2,143 Reduced 47.95%
2,326 $437,000
Q4 2021

Feb 09, 2022

BUY
$247.59 - $304.47 $722,467 - $888,443
2,918 Added 188.14%
4,469 $1.18 Million
Q3 2021

Nov 10, 2021

SELL
$194.77 - $324.21 $519,256 - $864,343
-2,666 Reduced 63.22%
1,551 $448,000
Q2 2021

Aug 12, 2021

BUY
$165.87 - $220.95 $352,805 - $469,960
2,127 Added 101.77%
4,217 $842,000
Q1 2021

May 13, 2021

BUY
$180.37 - $226.26 $56,996 - $71,498
316 Added 17.81%
2,090 $406,000
Q4 2020

Feb 12, 2021

BUY
$148.08 - $206.57 $61,008 - $85,106
412 Added 30.25%
1,774 $340,000
Q3 2020

Nov 12, 2020

BUY
$122.51 - $158.27 $166,858 - $215,563
1,362 New
1,362 $201,000
Q1 2020

May 13, 2020

SELL
$84.96 - $109.14 $429,727 - $552,030
-5,058 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$73.84 - $93.08 $85,359 - $107,600
-1,156 Reduced 18.6%
5,058 $468,000
Q3 2019

Nov 12, 2019

BUY
$76.65 - $95.51 $476,303 - $593,499
6,214 New
6,214 $477,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.59B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Alpha Crest Capital Management LLC Portfolio

Follow Alpha Crest Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.